c-Jun N-terminal kinase (JNK) signaling: Recent advances and challenges

Kyriakis, 1990, pp54 microtubule-associated protein 2 kinase. A novel serine/threonine protein kinase regulated by phosphorylation and stimulated by poly-l-lysine, J. Biol. Chem., 265, 17355, 10.1016/S0021-9258(17)44910-6 Kyriakis, 1991, pp54 microtubule-associated protein-2 kinase requires both tyrosine and threonine phosphorylation for activity, J. Biol. Chem., 266, 10043, 10.1016/S0021-9258(18)99183-0 Hibi, 1993, Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain, Genes Dev., 7, 2135, 10.1101/gad.7.11.2135 Dérijard, 1994, JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain, Cell, 76, 1025, 10.1016/0092-8674(94)90380-8 Kyriakis, 1994, The stress-activated protein kinase subfamily of c-Jun kinases, Nature, 369, 156, 10.1038/369156a0 Kallunki, 1994, JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation, Genes Dev., 8, 2996, 10.1101/gad.8.24.2996 Yang, 1997, Absence of excitotoxicity induced apoptosis in the hippocampus of mice lacking the Jnk3 gene, Nature, 389, 865, 10.1038/39899 Kuan, 2003, A critical role of neural-specific JNK3 for ischemic apoptosis, Proc. Natl. Acad. Sci. U. S. A., 100, 15184, 10.1073/pnas.2336254100 Sabapathy, 1999, Defective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2, Mech. Dev., 89, 115, 10.1016/S0925-4773(99)00213-0 Kuan, 1999, The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development, Neuron, 22, 667, 10.1016/S0896-6273(00)80727-8 Dong, 2002, MAP kinases in the immune response, Ann. Rev. Immunol., 20, 55, 10.1146/annurev.immunol.20.091301.131133 Bogoyevitch, 2006, The isoform-specific functions of the c-Jun N-terminal kinases (JNKs)—differences revealed by gene targeting, BioEssays, 28, 923, 10.1002/bies.20458 Hirosumi, 2002, A central role for JNK in obesity and insulin resistance, Nature, 420, 333, 10.1038/nature01137 Jaeschke, 2005, Disruption of the Jnk2 (Mapk9) gene reduces destructive insulitis and diabetes in a mouse model of type I diabetes, Proc. Natl. Acad. Sci. U. S. A., 102, 6931, 10.1073/pnas.0502143102 Han, 2002, Joint damage and inflammation in c-Jun N-terminal kinase 2 knockout mice with passive murine collagen-induced arthritis, Arthritis Rheum., 46, 818, 10.1002/art.10104 Gupta, 1996, Selective interaction of JNK protein kinase isoforms with transcription factors, EMBO J., 15, 2760, 10.1002/j.1460-2075.1996.tb00636.x Xie, 1998, Crystal structure of JNK3: a kinase implicated in neuronal apoptosis, Structure, 6, 983, 10.1016/S0969-2126(98)00100-2 Heo, 2004, Structural basis for the selective inhibition of JNK1 by the scaffolding protein JIP1 and SP600125, EMBO J., 23, 2185, 10.1038/sj.emboj.7600212 Shaw, 2008, The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity, J. Mol. Biol., 383, 885, 10.1016/j.jmb.2008.08.086 Dickens, 1997, A cytoplasmic inhibitor of the JNK signal transduction pathway, Science, 277, 693, 10.1126/science.277.5326.693 Whitmarsh, 1998, A mammalian scaffold complex that selectively mediates MAP kinase activation, Science, 281, 1671, 10.1126/science.281.5383.1671 Yasuda, 1999, The JIP group of mitogen-activated protein kinase scaffold proteins, Mol. Cell. Biol., 19, 7245, 10.1128/MCB.19.10.7245 Bennett, 2001, SP600125, and anthrapyrazolone inhibitor of Jun N-terminal kinase, Proc. Natl. Acad. Sci. U. S. A., 98, 13681, 10.1073/pnas.251194298 Xia, 1995, Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis, Science, 270, 1326, 10.1126/science.270.5240.1326 Park, 1997, Activation of c-Jun N-terminal kinase antagonizes an anti-apoptotic action of Bcl-2, J. Biol. Chem., 272, 16725, 10.1074/jbc.272.27.16725 Tournier, 2000, Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway, Science, 288, 870, 10.1126/science.288.5467.870 Borsello, 2003, A peptide inhibitor of c-Jun N-terminal kinase protects against excitotoxicity and cerebral ischemia, Nat. Med., 9, 1180, 10.1038/nm911 Bogoyevitch, 2008, Inhibitors of c-Jun N-terminal kinases: JuNK no more?, Biochim. Biophys. Acta, 1784, 76, 10.1016/j.bbapap.2007.09.013 Asano, 2008, Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (1), Bioorg. Med. Chem., 16, 4715, 10.1016/j.bmc.2008.02.027 Asano, 2008, Discovery, synthesis and biological evaluation of isoquinolones as novel and highly selective JNK inhibitors (2), Bioorg. Med. Chem., 16, 4699, 10.1016/j.bmc.2008.02.028 Alam, 2007, Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors, Bioorg. Med. Chem. Lett., 17, 3463, 10.1016/j.bmcl.2007.03.078 Shin, 2009, Synthesis and SAR of piperazine amides as novel c-jun N-terminal kinase (JNK) inhibitors, Bioorg. Med. Chem. Lett., 19, 3344, 10.1016/j.bmcl.2009.03.086 Kamenecka, 2009, Structure–Activity relationships and X-ray structures describing the selectivity of aminopyrazole inhibitors for c-Jun N-terminal kinase 3 (JNK3) over p38., J. Biol. Chem., 284, 12853, 10.1074/jbc.M809430200 Angell, 2007, N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3, Bioorg. Med. Chem. Lett., 17, 1296, 10.1016/j.bmcl.2006.12.003 Christopher, 2009, 1-Aryl-3,4-dihydroisoquinoline inhibitors of JNK3, Bioorg. Med. Chem. Lett., 19, 2230, 10.1016/j.bmcl.2009.02.098 Jiang, 2007, 3,5-Disubstituted quinolines as novel c-Jun N-terminal kinase inhibitors, Bioorg. Med. Chem. Lett., 17, 6378, 10.1016/j.bmcl.2007.08.054 Humphries, 2009, Synthesis and SAR of 4-substituted-2-aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors, Bioorg. Med. Chem. Lett., 19, 2099, 10.1016/j.bmcl.2009.03.023 Resnick, 2004, Targeting JNK3 for the treatment of neurodegenerative disorders, Drug Discov. Today, 9, 932, 10.1016/S1359-6446(04)03251-9 Liu, 2007, Discovery of a new class of 4-anilinopyrimidines as potent c-Jun N-terminal kinase inhibitors: synthesis and SAR studies, Bioorg. Med. Chem. Lett., 17, 668, 10.1016/j.bmcl.2006.10.093 Cho, 2008, Pharmacological characterization of a small molecule inhibitor of c-Jun kinase, Am. J. Physiol., 295, E1142 Liu, 2007, Hemodynamic effects of potent and selective JNK inhibitors in anesthetized rats: implication for targeting protein kinases in metabolic diseases, Bioorg. Med. Chem. Lett., 17, 495, 10.1016/j.bmcl.2006.10.013 Mendonsa, 2009, Molecular profiling reveals diversity of stress signal transduction cascades in highly penetrant Alzheimer's disease human skin fibroblasts, PLoS ONE, 4, e4655, 10.1371/journal.pone.0004655 Mucha, 2009, JNK inhibition sensitises hepatocellular carcinoma cells but not normal hepatocytes to the TNF-related apoptosis-inducing ligand, Gut, 58, 688, 10.1136/gut.2008.154625 Goldstein, 2008, High-throughput kinase profiling as a platform for drug discovery, Nat. Rev. Drug Discov., 7, 391, 10.1038/nrd2541 Bogoyevitch, 2005, Therapeutic promise of JNK ATP-noncompetitive inhibitors, Trends Mol. Med., 11, 232, 10.1016/j.molmed.2005.03.005 Repici, 2007, Time-course of c-Jun N-terminal kinase activation after cerebral ischemia and effect of D-JNKI1 on c-Jun and caspase-3 activation, Neuroscience, 150, 40, 10.1016/j.neuroscience.2007.08.021 Wiegler, 2008, The JNK inhibitor XG-102 protects from ischemic damage with delayed intravenous administration also in the presence of recombinant tissue plasminogen activator, Cerebrovasc. Dis., 26, 360, 10.1159/000151639 Esneault, 2008, D-JNKi, a peptide inhibitor of c-Jun N-terminal kinase, promotes functional recovery after transient focal cerebral ischemia in rats, Neuroscience, 152, 308, 10.1016/j.neuroscience.2007.12.036 Ginet, 2009, Limited role of the c-Jun N-terminal kinase pathway in a neonatal rat model of cerebral hypoxia–ischemia, J. Neurochem., 108, 552, 10.1111/j.1471-4159.2008.05797.x Eshraghi, 2007, Blocking c-Jun-N-terminal kinase signaling can prevent hearing loss induced by both electrode insertion trauma and neomycin ototoxicity, Hear. Res., 226, 168, 10.1016/j.heares.2006.09.008 Wang, 2007, Inhibition of the c-Jun N-terminal kinase-mediated mitochondrial cell death pathway restores auditory function in sound-exposed animals, Mol. Pharmacol., 71, 654, 10.1124/mol.106.028936 Suckfuell, 2007, Intratympanic treatment of acute acoustic trauma with a cell-permeable JNK ligand: a prospective randomized phase I/II study, Acta Otolaryngol., 127, 938, 10.1080/00016480601110212 Barkdull, 2007, AM-111 reduces hearing loss in a guinea pig model of acute labyrinthitis, Laryngoscope, 117, 2174, 10.1097/MLG.0b013e3181461f92 Beckham, 2007, Novel strategy for treatment of viral central nervous system infection by using a cell-permeating inhibitor of c-Jun N-terminal kinase, J. Virol., 81, 6984, 10.1128/JVI.00467-07 Sury, 2008, JNK is activated but does not mediate hippocampal neuronal apoptosis in experimental neonatal pneumococcal meningitis, Neurobiol. Dis., 32, 142, 10.1016/j.nbd.2008.07.006 Palin, 2008, Tumor necrosis factor-alpha-induced sickness behavior is impaired by central administration of an inhibitor of c-jun N-terminal kinase, Psychopharmacology, 197, 629, 10.1007/s00213-008-1086-y Repici, 2008, Specific JNK inhibition by D-JNKI1 protects Purkinje cells from cell death in Lurcher mutant mouse, Cerebellum, 7, 534, 10.1007/s12311-008-0070-8 Pain, 2008, A cell-permeable peptide inhibitor TAT-JBD reduces the MPP+-induced caspase-9 activation but does not prevent the dopaminergic degeneration in substantia nigra of rats, Toxicology, 243, 124, 10.1016/j.tox.2007.09.033 Gao, 2009, JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain., J. Neurosci., 29, 4096, 10.1523/JNEUROSCI.3623-08.2009 Colombo, 2009, JNK regulates APP cleavage and degradation in a model of Alzheimer's disease, Neurobiol. Dis., 33, 518, 10.1016/j.nbd.2008.12.014 Gao, 2009, Selective inhibition of JNK with a peptide inhibitor attenuates pain hypersensitivity and tumor growth in a mouse skin cancer pain model, Exp. Neurol., 219, 146, 10.1016/j.expneurol.2009.05.006 Farías, 2009, Wnt-5a/JNK signaling promotes the clustering of PSD-95 in hippocampal neurons, J. Biol. Chem., 284, 15857, 10.1074/jbc.M808986200 Fornoni, 2007, The L-isoform but not D-isoforms of a JNK inhibitory peptide protects pancreatic b-cells, Biochem. Biophys. Res. Commun., 354, 227, 10.1016/j.bbrc.2006.12.186 Ijaz, 2009, Inhibition of C-jun N-terminal kinase improves insulin sensitivity but worsens albuminuria in experimental diabetes., Kidney Int., 75, 381, 10.1038/ki.2008.559 Kato, 2008, Distinct role of c-Jun N-terminal kinase isoforms in human neutrophil apoptosis regulated by tumor necrosis factor-alpha and granulocyte-macrophage colony-stimulating factor, J. Interferon. Cytokine Res., 28, 235, 10.1089/jir.2007.0075 Melino, 2008, The effect of the JNK inhibitor, JIP peptide, on human T lymphocyte proliferation and cytokine production, J. Immunol., 181, 7300, 10.4049/jimmunol.181.10.7300 Crisostomo, 2008, Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism, Am. J. Physiol. Cell Physiol., 294, C675, 10.1152/ajpcell.00437.2007 Hui, 2008, Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation, J. Clin. Invest., 118, 3943, 10.1172/JCI37156 Lehnert, 2008, A peptide inhibitor of C-jun N-terminal kinase modulates hepatic damage and the inflammatory response after hemorrhagic shock and resuscitation, Shock, 30, 159, 10.1097/SHK.0b013e31815dd623 Relja, 2009, Inhibition of c-Jun N-terminal Kinase after hemorrhage but before resuscitation mitigates hepatic damage and the inflammatory response in female rats, Shock., 32, 509, 10.1097/SHK.0b013e3181a2530d Wu, 2009, Inhibition of JNK enhances TGF-beta1-activated Smad2 signaling in mouse embryonic lung., Pediatr. Res., 65, 381, 10.1203/PDR.0b013e3181991c67 Medhora, 2008, Role of JNK in network formation of human lung microvascular endothelial cells, Am. J. Physiol., 294, L676 Guma, 2009, Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression, Proc. Natl. Acad. Sci. U. S. A., 106, 8760, 10.1073/pnas.0902659106 Ahmed, 2009, c-Jun N-terminal kinases inhibitor suppresses the TNF-alpha induced MCP-1 expression in human umbilical vein endothelial cells, Endocrine, 35, 184, 10.1007/s12020-008-9136-0 Repici, 2009, Neuroscience, 159, 94, 10.1016/j.neuroscience.2008.11.049 Barr, 2002, Identification of the critical features of a small peptide inhibitor of JNK activity, J. Biol. Chem., 277, 10987, 10.1074/jbc.M107565200 Bonny, 2001, Cell-permeable inhibitors of JNK: novel blockers of b-cell death, Diabetes, 50, 77, 10.2337/diabetes.50.1.77 Barr, 2004, The critical features and the mechanism of inhibition of a kinase interaction motif-based peptide inhibitor of JNK, J. Biol. Chem., 279, 36327, 10.1074/jbc.M402181200 Chène, 2008, Challenges in design of biochemical assays for the identification of small molecules to target multiple conformations of protein kinases, Drug Discov. Today, 13, 522, 10.1016/j.drudis.2008.03.023 Akritopoulou-Zanze, 2009, Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors, Drug Discov. Today, 14, 291, 10.1016/j.drudis.2008.12.002 Stebbins, 2008, Identification of a new JNK inhibitor targeting the JNK–JIP interaction site., Proc. Natl. Acad. Sci. U. S. A., 105, 16809, 10.1073/pnas.0805677105 De, 2009, Design, synthesis, and structure–activity relationship of substrate competitive, selective, and in vivo active triazole and thiadiazole inhibitors of the c-Jun N-terminal kinase, J. Med. Chem., 52, 1943, 10.1021/jm801503n De, 2009, Discovery of 2-(5-nitrothiazol-2-ylthio)benzo[d]thiazoles as novel c-Jun N-terminal kinase inhibitors, Bioorg. Med. Chem., 17, 2712, 10.1016/j.bmc.2009.02.046 Borhani, 2009, Covalent JNK inhibitors?, Proc. Natl. Acad. Sci. U. S. A., 106, E18, 10.1073/pnas.0812246106 Pellecchia, 2009, Covalent JNK inhibitors?, Proc. Natl. Acad. Sci. U. S. A., 106 Chen, 2009, Identification of small-molecule inhibitors of the JIP–JNK interaction, Biochem. J., 420, 283, 10.1042/BJ20081899 Scapin, 2003, The structure of JNK3 in complex with small molecule inhibitors: structural basis for potency and selectivity, Chem. Biol., 10, 705, 10.1016/S1074-5521(03)00159-5 Swahn, 2005, Design and synthesis of 6-anilinoindazoles as selective inhibitors of c-Jun N-terminal kinase-3, Bioorg. Med. Chem. Lett., 15, 5095, 10.1016/j.bmcl.2005.06.083 Swahn, 2006, Design and synthesis of 2′-anilino-4,4′-bipyridines as selective inhibitors of c-Jun N-terminal kinase-3, Bioorg. Med. Chem. Lett., 16, 1397, 10.1016/j.bmcl.2005.11.039 Zhao, 2006, Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitors, J. Med. Chem., 49, 4455, 10.1021/jm060465l Liu, 2006, Aminopyridine carboxamides as c-Jun N-terminal kinase inhibitors: targeting the gatekeeper residue and beyond, Bioorg. Med. Chem. Lett., 16, 5723, 10.1016/j.bmcl.2006.08.097 Szczepankiewicz, 2006, Aminopyridine-based c-Jun N-terminal kinase inhibitors with cellular activity and minimal cross-kinase activity, J. Med. Chem., 49, 3563, 10.1021/jm060199b Liu, 2007, Discovery of a new class of 4-anilinopyrimidines as potent c-Jun N-terminal kinase inhibitors: synthesis and SAR studies, Bioorg. Med. Chem. Lett., 17, 668, 10.1016/j.bmcl.2006.10.093 Ember, 2008, Mechanistic characterization for c-jun-N-terminal kinase 1alpha1., Arch. Biochem. Biophys., 477, 324, 10.1016/j.abb.2008.06.001 Niu, 2007, Kinetic characterization of human JNK2alpha2 reaction mechanism using substrate competitive inhibitors, Biochemistry, 46, 4775, 10.1021/bi602423e Ember, 2008, Kinetic mechanism and inhibitor characterization for c-jun-N-terminal kinase 3alpha1, Biochemistry, 47, 3076, 10.1021/bi701852z Pellecchia, 2008, Perspectives on NMR in drug discovery: a technique comes of age, Nat. Rev. Drug Discov., 7, 738, 10.1038/nrd2606 Vazquez, 2008, Development of paramagnetic probes for molecular recognition studies in protein kinases., J. Med. Chem., 51, 3460, 10.1021/jm800068w Ho, 2006, Interacting JNK-docking sites in MKK7 promote binding and activation of JNK mitogen-activated protein kinases, J. Biol. Chem., 281, 13169, 10.1074/jbc.M601010200 Whitmarsh, 2001, Requirement of the JIP1 scaffold protein for stress-induced JNK activation., Genes Dev., 15, 2421, 10.1101/gad.922801 Jaeschke, 2004, An essential role of the JIP1 scaffold protein for JNK activation in adipose tissue, Genes Dev., 18, 1976, 10.1101/gad.1216504 Dajas-Bailador, 2008, The JIP1 scaffold protein regulates axonal development in cortical neurons., Curr. Biol., 18, 221, 10.1016/j.cub.2008.01.025 Thompson, 2001, Islet-brain1/JNK interacting protein-1 is required for early embryogenesis in mice, J. Biol. Chem., 276, 27745, 10.1074/jbc.C100222200 Yang, 2007, Splice variant-specific stabilization of JNKs by IB1/JIP1, Cell Signal., 19, 2201, 10.1016/j.cellsig.2007.07.001 Nihalani, 2007, Src family kinases directly regulate JIP1 module dynamics and activation, Mol. Cell. Biol., 27, 2431, 10.1128/MCB.01479-06 Xie, 2008, The docking properties of SHIP2 influence both JIP1 tyrosine phosphorylation and JNK activity, Cell Signal., 20, 1432, 10.1016/j.cellsig.2008.03.010 Santos, 2006, Vaccinia virus B1R kinase interacts with JIP1 and modulates c-Jun-dependent signaling, J. Virol., 80, 7667, 10.1128/JVI.00967-06 Tapon, 1998, A new Rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kB signalling pathways, EMBO J., 17, 1395, 10.1093/emboj/17.5.1395 Xu, 2003, POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis, EMBO J., 22, 252, 10.1093/emboj/cdg021 Zhang, 2005, Knock-down of POSH expression is neuroprotective through down-regulating activation of the MLK3–MKK4–JNK pathway following cerebral ischaemia in the rat hippocampal CA1 subfield, J. Neurochem., 95, 784, 10.1111/j.1471-4159.2005.03435.x McDonald, 2000, b-Arrestin 2: a receptor-regulated MAPK scaffold for the activation of JNK3, Science, 290, 1574, 10.1126/science.290.5496.1574 Guo, 2008, The beta-arrestin-2 scaffold protein promotes c-Jun N-terminal kinase-3 activation by binding to its nonconserved N terminus, J. Biol. Chem., 283, 15903, 10.1074/jbc.M710006200 López-Bergami, 2005, RACK1 mediates activation of JNK by protein kinase C, Mol. Cell, 19, 309, 10.1016/j.molcel.2005.06.025 Ye, 2007, GRASP-1 is a neuronal scaffold protein for the JNK signaling pathway, FEBS Lett., 581, 4403, 10.1016/j.febslet.2007.08.008 Jeon, 2008, Filamin B serves as a molecular scaffold for type I interferon-induced c-Jun NH2-terminal kinase signaling pathway., Mol. Biol. Cell, 19, 5116, 10.1091/mbc.E08-06-0576 Kadoya, 2005, JAMP, a Jun N-terminal kinase 1 (JNK1)-associated membrane protein, regulates duration of JNK activity, Mol. Cell. Biol., 25, 8619, 10.1128/MCB.25.19.8619-8630.2005 Lalioti, 2009, Daxx functions as a scaffold of a protein assembly constituted by GLUT4, JNK1 and KIF5B, J. Cell Physiol., 218, 416, 10.1002/jcp.21614 López-Sánchez, 2007, Mitochondrial c-Jun NH2-terminal kinase prevents the accumulation of reactive oxygen species and reduces necrotic damage in neural tumor cells that lack trophic support, Mol. Cancer Res., 5, 47, 10.1158/1541-7786.MCR-06-0233 Hanawa, 2008, Role of JNK translocation to mitochondria leading to inhibition of mitochondria bioenergetics in acetaminophen-induced liver injury, J. Biol. Chem., 283, 13565, 10.1074/jbc.M708916200 Nagata, 1988, The MAP kinase kinase kinase MLK2 co-localizes with activated JNK along microtubules and associates with kinesin superfamily motor KIF3, EMBO J., 17, 149, 10.1093/emboj/17.1.149 Good, 2009, The Ste5 scaffold directs mating signaling by catalytically unlocking the Fus3 MAP kinase for activation., Cell, 136, 1085, 10.1016/j.cell.2009.01.049 Matsuzawa, 2008, Essential cytoplasmic translocation of a cytokine receptor-assembled signaling complex, Science, 321, 663, 10.1126/science.1157340 Bogoyevitch, 2006, Uses for JNK—the many and varied Substrates of c-Jun N-terminal Kinases, Microbiol. Mol. Biol. Rev., 70, 1061, 10.1128/MMBR.00025-06 Chen, 1996, The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation, J. Biol. Chem., 271, 31929, 10.1074/jbc.271.50.31929 Park, 2007, Phosphorylation of Smac by JNK3 attenuates its interaction with XIAP, Biochem. Biophys. Res. Commun., 361, 994, 10.1016/j.bbrc.2007.07.121 Leung, 2008, Activation of the JNK pathway promotes phosphorylation and degradation of BimEL—a novel mechanism of chemoresistance in T-cell acute lymphoblastic leukemia, Carcinogenesis, 29, 544, 10.1093/carcin/bgm294 Mielke, 2008, Growth-arrest-dependent expression and phosphorylation of p27kip at serine10 is mediated by the JNK pathway in C6 glioma cells, Mol. Cell. Neurosci., 38, 301, 10.1016/j.mcn.2007.12.007 Wu, 2008, JNK1 regulates histone acetylation in trigeminal neurons following chemical stimulation, Biochem. Biophys. Res. Commun., 376, 781, 10.1016/j.bbrc.2008.09.073 Gorentla, 2009, Proline-directed phosphorylation of the dopamine transporter N-terminal domain, Biochemistry, 48, 1067, 10.1021/bi801696n Choi, 2009, c-Jun N-terminal kinase 1 phosphorylates Myt1 to prevent UVA-induced skin cancer, Mol. Cell. Biol., 29, 2168, 10.1128/MCB.01508-08 Awano, 2008, Phosphorylation of protein phosphatase 2Czeta by c-Jun NH2-terminal kinase at Ser92 attenuates its phosphatase activity, Biochemistry, 47, 7248, 10.1021/bi800067p Morel, 2009, Mcl-1 integrates the opposing actions of signaling pathways that mediate survival and apoptosis, Mol. Cell. Biol., 29, 3845, 10.1128/MCB.00279-09 Lin, 2009, Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway, FEBS J., 276, 2022, 10.1111/j.1742-4658.2009.06938.x Zhou, 2008, c-Jun N-terminal kinase regulates mitochondrial bioenergetics by modulating pyruvate dehydrogenase activity in primary cortical neurons, J. Neurochem., 104, 325 Eminel, 2004, JNK2 translocates to the mitochondria and mediates cytochrome c release in PC12 cells in response to 6-hydroxydopamine, J. Biol. Chem., 279, 55385, 10.1074/jbc.M405858200 Ogata, 2006, Autophagy is activated for cell survival after endoplasmic reticulum stress, Mol. Cell. Biol., 26, 9220, 10.1128/MCB.01453-06 Wei, 2008, JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy, Mol. Cell, 30, 678, 10.1016/j.molcel.2008.06.001 Wei, 2008, Dual role of JNK1-mediated phosphorylation of Bcl-2 in autophagy and apoptosis regulation, Autophagy, 4, 949, 10.4161/auto.6788 Li, 2009, The pivotal role of c-Jun NH2-terminal kinase-mediated Beclin 1 expression during anticancer agents-induced autophagy in cancer cells, Oncogene, 28, 886, 10.1038/onc.2008.441 Park, 2009, Upregulation of Beclin-1 expression and phosphorylation of Bcl-2 and p53 are involved in the JNK-mediated autophagic cell death, Biochem. Biophys. Res. Commun., 382, 726, 10.1016/j.bbrc.2009.03.095 Wu, 2009, JNK protects Drosophila from oxidative stress by trancriptionally activating autophagy, Mech. Dev., 126, 624, 10.1016/j.mod.2009.06.1082 Nishida, 2008, Crosstalk between autophagy and apoptosis in heart disease, Circ. Res., 103, 343, 10.1161/CIRCRESAHA.108.175448 Shaw, 2008, Molecular regulation of autophagy and apoptosis during ischemic and non-ischemic cardiomyopathy., Autophagy, 4, 427, 10.4161/auto.5901 Brodersen, 2009, Revisiting the principles of microRNA target recognition and mode of action, Nat. Rev. Mol. Cell Biol., 10, 141, 10.1038/nrm2619 Chua, 2009, MicroRNAs: biogenesis, function and applications, Curr. Opin. Mol. Ther., 11, 189 O'Connell, 2007, MicroRNA-155 is induced during the macrophage inflammatory response, Proc. Natl. Acad. Sci. U. S. A., 104, 1604, 10.1073/pnas.0610731104 Yin, 2008, B-cell receptor activation induces BIC/miR-155 expression through a conserved AP-1 element, J. Biol. Chem., 283, 2654, 10.1074/jbc.M708218200 Rozo, 2008, Silencing Jnk1 and Jnk2 accelerates basal lipolysis and promotes fatty acid re-esterification in mouse adipocytes, Diabetologia, 51, 1493, 10.1007/s00125-008-1036-6 Varona-Santos, 2008, c-Jun N-terminal kinase 1 is deleterious to the function and survival of murine pancreatic islets, Diabetologia, 51, 2271, 10.1007/s00125-008-1169-7 Fukuda, 2008, c-Jun amino terminal kinase 1 deficient mice are protected from streptozotocin-induced islet injury, Biochem. Biophys. Res. Commun., 366, 710, 10.1016/j.bbrc.2007.12.007 Singh, 2009, Differential effects of JNK1 and JNK2 inhibition on murine steatohepatitis and insulin resistance, Hepatology, 49, 87, 10.1002/hep.22578 Kodama, 2009, c-Jun N-terminal kinase signaling in the pathogenesis of nonalcoholic fatty liver disease: multiple roles in multiple steps, Hepatology, 49, 6, 10.1002/hep.22710 Tong, 2007, c-Jun NH2-terminal kinase 1 plays a critical role in intestinal homeostasis and tumor suppression, Am. J. Pathol., 171, 297, 10.2353/ajpath.2007.061036 Yang, 2007, Liver-specific knockdown of JNK1 upregulates PGC-1beta and increases plasma triglyceride despite reduced glucose and insulin levels in diet-induced diabetic mice, J. Biol. Chem., 282, 22765, 10.1074/jbc.M700790200 Solinas, 2007, JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity, Cell Metab., 6, 386, 10.1016/j.cmet.2007.09.011 Das, 2007, Suppression of p53-dependent senescence by the JNK signal transduction pathway, Proc. Natl. Acad. Sci. U. S. A., 104, 15759, 10.1073/pnas.0707782104 Das, 2009, Induction of hepatitis by JNK-mediated expression of TNF-alpha, Cell, 136, 249, 10.1016/j.cell.2008.11.017 Ma, 2009, Blockade of the c-Jun amino terminal kinase prevents crescent formation and halts established anti-GBM glomerulonephritis in the rat, Lab. Invest., 89, 470, 10.1038/labinvest.2009.2 Sabio, 2008, A stress signaling pathway in adipose tissue regulates hepatic insulin resistance, Science, 322, 1539, 10.1126/science.1160794 Liu, 2009, Cardiac-specific deletion of mkk4 reveals its role in pathological hypertrophic remodeling but not in physiological cardiac growth, Circ. Res., 104, 905, 10.1161/CIRCRESAHA.108.188292 Petrich, 2003, Temporal activation of c-Jun N-terminal kinase in adult transgenic heart via cre-loxP-mediated DNA recombination, FASEB J., 17, 749, 10.1096/fj.02-0438fje Waetzig, 2008, c-Jun N-terminal kinases mediate Fas-induced neurite regeneration in PC12 cells, Biochem. Pharmacol., 76, 1476, 10.1016/j.bcp.2008.07.014 Waetzig, 2009, Concurrent protective and destructive signaling of JNK2 in neuroblastoma cells., Cell. Signal., 21, 873, 10.1016/j.cellsig.2009.01.032